Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
OSE Immuno (OSE FP)
Watchlist
36
Analysis
Health Care
•
France
OSE Immunotherapeutics SA is a biotechnology company based in France, developing immunotherapy products against invasive/metastatic late-stage cancers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
OSE Immuno
•
06 Jul 2023 21:18
•
Issuer-paid
OSE Immunotherapeutics - Lusvertikimab progressing on multiple fronts
OSE has announced that Lusvertikimab (or OSE-127), the company’s most advanced asset in the immuno-inflammation space, has received a positive...
Edison Investment Research
Follow
241 Views
Share
bullish
•
OSE Immuno
•
05 Jul 2023 23:26
•
Issuer-paid
OSE Immunotherapeutics - US patent to bolster Tedopi’s product portfolio
OSE Immunotherapeutics has announced that Tedopi, the company’s lead cancer vaccine candidate, has been granted a new patent by the United States...
Edison Investment Research
Follow
357 Views
Share
bullish
•
OSE Immuno
•
26 Jun 2023 15:50
•
Issuer-paid
OSE Immunotherapeutics - New diagnostic test to support Tedopi trial
OSE Immunotherapeutics (OSE) has received €1.5m in non-dilutive funding from Bpifrance (a French public sector investment bank) to develop a...
Edison Investment Research
Follow
107 Views
Share
bullish
•
OSE Immuno
•
24 May 2023 19:24
•
Issuer-paid
OSE Immunotherapeutics - Milestones anticipated throughout FY23
OSE Immunotherapeutics has announced its FY22 results, providing financial and operational updates as the company continues to advance its key...
Edison Investment Research
Follow
190 Views
Share
bullish
•
OSE Immuno
•
01 Mar 2023 15:40
•
Issuer-paid
OSE Immunotherapeutics - Encouraging safety data for OSE-127
OSE Immunotherapeutics has announced that the data from its earlier Phase I study for OSE-127/S95011, initially released in 2019, has been...
Edison Investment Research
Follow
213 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x